Ims Health Holdings Inc (IMS) 30.50 $IMS
IMS Health (IMS) Prices Upsized Offering of Senior Notes
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 10:14AM CDT
IMS Health Holdings, Inc. (IMS) announced the pricing of a senior notes offering worth $1.75 billion.
IMS: 30.50 (+0.50), USPH: 62.69 (-0.31), Q: 79.41 (+1.28), RDNT: 7.32 (unch)
IMS Health Announces Pricing on Upsized Offering of Senior Notes In Connection with Quintiles IMS Merger
BusinessWire - Wed Sep 14, 10:10AM CDT
IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of $1.75 billion equivalent in gross proceeds of senior notes, consisting of $1.05 billion of U.S. Dollar notes and EUR625 million of Euro notes to be issued by its wholly owned subsidiary, IMS Health Incorporated. The offering was upsized from the previously announced $1.5 billion equivalent aggregate principal amount. The net proceeds from the notes offering (together with proceeds from additional term loans and other available cash) will primarily be used to extinguish certain of the issuer's and Quintiles' existing indebtedness in connection with the previously announced proposed merger between IMS Health and Quintiles.
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
IMS Health Announces Offering of Senior Notes In Connection with Quintiles IMS Merger
BusinessWire - Mon Sep 12, 7:03AM CDT
IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.5 billion equivalent in gross proceeds through an offering of senior notes. The company is planning to issue two separate tranches of notes, one in U.S. Dollars, due 2026, and another in Euros, due 2024. The net proceeds from the notes offering (together with proceeds from additional term loans and other available cash) will primarily be used to extinguish certain of the issuer's and Quintiles' existing indebtedness in connection with the previously announced proposed merger between IMS Health and Quintiles. The consummation of the notes offering is subject to market and other conditions and is mandatorily redeemable if the merger does not occur.
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
The IMS Institute for Healthcare Informatics Launches Asia Branch
BusinessWire - Thu Sep 01, 8:00AM CDT
The IMS Institute for Healthcare Informatics today announced the launch of a new branch focused on supporting improved health outcomes across Asia. Based in Singapore, the team will forge relationships in the public and private sectors and apply analytics-driven approaches, based on Real-World Evidence, for disease modeling and insights--providing regional markets with much-needed tools to make better and more cost-effective healthcare policy decisions.
IMS: 30.50 (+0.50)
IMS Health and Quintiles Announce Key Officers for Merged Company
BusinessWire - Mon Aug 29, 5:45AM CDT
IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) today announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of the merger.
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
IT Services Stocks Under Scanner -- Computer Sciences, 21Vianet, CSRA, and IMS Health
PR Newswire - Tue Aug 23, 7:10AM CDT
The Information Technology Services space includes companies that provide software support services, computer systems design, and data processing facilities management. Key challenges that have been impacting the industry are macroeconomic conditions, increasing use of automation, and digital disruption. Stock-Callers.com takes a look at these equities and see where they stand in the market today: Computer Sciences Corp. (NYSE: CSC), 21Vianet Group Inc. (NASDAQ: VNET), CSRA Inc. (NYSE: CSRA), and IMS Health Holdings Inc. (NYSE: IMS). You can access of our complimentary research reports on these stocks now at:
VNET: 8.51 (unch), IMS: 30.50 (+0.50), CSC: 51.57 (-0.30), CSRA: 27.12 (-0.01)
Moving Average Crossover Alert: IMS Health Holdings (IMS)
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:47AM CDT
IMS Health Holdings, Inc. (IMS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
IMS: 30.50 (+0.50)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces a Class Action has Been Commenced Challenging the Fairness of the Sale of IMS Health Holdings, Inc. to Quintiles Transnational Holdings, Inc. -- IMS
GlobeNewswire - Fri Jun 17, 9:19AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
Information Technology Services Stocks Scanner - Computer Sciences, IMS Health Holdings, NCR Corp., and Unisys
PR Newswire - Wed Jun 08, 7:15AM CDT
On Tuesday, June 07, 2016, the NASDAQ Composite ended the trading session at 4,961.75, down 0.14%; the Dow Jones Industrial Average advanced 0.10% to finish at 17,938.28; and the S&P 500 closed at 2,112.13, up 0.13%. The gains were broad based as eight out of nine sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Computer Sciences Corporation (NYSE: CSC), IMS Health Holdings Inc. (NYSE: IMS), NCR Corporation (NYSE: NCR), and Unisys Corporation (NYSE: UIS). Learn more about these stocks by accessing their free trade alerts at:
IMS: 30.50 (+0.50), CSC: 51.57 (-0.30), NCR: 31.74 (-0.20), UIS: 9.45 (+0.04)
IMS Health Study: Global Market for Cancer Treatments Grows to $107 Billion in 2015, Fueled by Record Level of Innovation
BusinessWire - Wed Jun 01, 11:01PM CDT
More than 20 tumor types are being treated with one or more of the 70 new cancer treatments that have been launched in the past five years, with the sustained surge in innovative therapies driving the global oncology market to $107 billion in 2015. However, many of these drugs are not yet available to patients in most countries, and even when registered they may not be reimbursed under public insurance programs, according to a new study released today by the IMS Institute for Healthcare Informatics.
IMS: 30.50 (+0.50)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of IMS Health Holdings, Inc. to Quintiles Transnational Holdings, Inc.
BusinessWire - Thu May 26, 2:06PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
Privacy Analytics Acquired by IMS Health
CNW Group - Thu May 26, 8:30AM CDT
Integrating innovative data privacy expertise with a global healthcare information & technology service leader, strengthening and driving Ontario's digital healthcare security footprint
IMS: 30.50 (+0.50)
IMS Health Acquires Privacy Analytics, Advancing Real-World Evidence Technology to Drive R&D and Commercial Performance
BusinessWire - Wed May 25, 8:00AM CDT
IMS Health (NYSE:IMS) has acquired Privacy Analytics Incorporated, a leader in technology solutions for de-identifying and anonymizing healthcare information, to extend its robust Real-World Evidence (RWE) capabilities. Affirming IMS Health's long-standing practices for safeguarding patient privacy, the acquisition advances the company's ability to help life sciences clients drive R&D and commercial performance and demonstrate treatment value in real-world settings. It also reinforces IMS Health's role as a partner of choice for health systems, payers, providers and researchers as they seek new insights from healthcare data--with strong support for responsible privacy management.
IMS: 30.50 (+0.50)
Harwood Feffer LLP Announces Investigation of IMS Health Holdings, Inc.
PR Newswire - Tue May 24, 3:16PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of IMS Health Holdings, Inc. ("IMS" or the "Company"
(NYSE: IMS) concerning the proposed acquisition of the Company by Quintiles Transnational Holdings Inc. ("Quintiles".
IMS: 30.50 (+0.50)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of IMS Health Holdings, Inc. to Quintiles Transnational Holdings, Inc.
BusinessWire - Mon May 23, 4:04PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of IMS Health Holdings, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Sat May 07, 5:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of IMS Health Holdings, Inc. ("IMS" or the "Company" (NYSE: IMS) relating to the proposed buyout of the Company by Quintiles Transnational Holdings, Inc.
IMS: 30.50 (+0.50)
IMS Health (IMS) Prices Upsized Offering of Senior Notes
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 10:14AM CDT
IMS Health Holdings, Inc. (IMS) announced the pricing of a senior notes offering worth $1.75 billion.
IMS: 30.50 (+0.50), USPH: 62.69 (-0.31), Q: 79.41 (+1.28), RDNT: 7.32 (unch)
IMS Health Announces Pricing on Upsized Offering of Senior Notes In Connection with Quintiles IMS Merger
BusinessWire - Wed Sep 14, 10:10AM CDT
IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of $1.75 billion equivalent in gross proceeds of senior notes, consisting of $1.05 billion of U.S. Dollar notes and EUR625 million of Euro notes to be issued by its wholly owned subsidiary, IMS Health Incorporated. The offering was upsized from the previously announced $1.5 billion equivalent aggregate principal amount. The net proceeds from the notes offering (together with proceeds from additional term loans and other available cash) will primarily be used to extinguish certain of the issuer's and Quintiles' existing indebtedness in connection with the previously announced proposed merger between IMS Health and Quintiles.
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
IMS Health Announces Offering of Senior Notes In Connection with Quintiles IMS Merger
BusinessWire - Mon Sep 12, 7:03AM CDT
IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.5 billion equivalent in gross proceeds through an offering of senior notes. The company is planning to issue two separate tranches of notes, one in U.S. Dollars, due 2026, and another in Euros, due 2024. The net proceeds from the notes offering (together with proceeds from additional term loans and other available cash) will primarily be used to extinguish certain of the issuer's and Quintiles' existing indebtedness in connection with the previously announced proposed merger between IMS Health and Quintiles. The consummation of the notes offering is subject to market and other conditions and is mandatorily redeemable if the merger does not occur.
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
The IMS Institute for Healthcare Informatics Launches Asia Branch
BusinessWire - Thu Sep 01, 8:00AM CDT
The IMS Institute for Healthcare Informatics today announced the launch of a new branch focused on supporting improved health outcomes across Asia. Based in Singapore, the team will forge relationships in the public and private sectors and apply analytics-driven approaches, based on Real-World Evidence, for disease modeling and insights--providing regional markets with much-needed tools to make better and more cost-effective healthcare policy decisions.
IMS: 30.50 (+0.50)
IMS Health and Quintiles Announce Key Officers for Merged Company
BusinessWire - Mon Aug 29, 5:45AM CDT
IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q) today announced key senior management roles in the future Quintiles IMS corporate leadership team, subject to the completion of the merger.
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
IT Services Stocks Under Scanner -- Computer Sciences, 21Vianet, CSRA, and IMS Health
PR Newswire - Tue Aug 23, 7:10AM CDT
The Information Technology Services space includes companies that provide software support services, computer systems design, and data processing facilities management. Key challenges that have been impacting the industry are macroeconomic conditions, increasing use of automation, and digital disruption. Stock-Callers.com takes a look at these equities and see where they stand in the market today: Computer Sciences Corp. (NYSE: CSC), 21Vianet Group Inc. (NASDAQ: VNET), CSRA Inc. (NYSE: CSRA), and IMS Health Holdings Inc. (NYSE: IMS). You can access of our complimentary research reports on these stocks now at:
VNET: 8.51 (unch), IMS: 30.50 (+0.50), CSC: 51.57 (-0.30), CSRA: 27.12 (-0.01)
Moving Average Crossover Alert: IMS Health Holdings (IMS)
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:47AM CDT
IMS Health Holdings, Inc. (IMS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
IMS: 30.50 (+0.50)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces a Class Action has Been Commenced Challenging the Fairness of the Sale of IMS Health Holdings, Inc. to Quintiles Transnational Holdings, Inc. -- IMS
GlobeNewswire - Fri Jun 17, 9:19AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
Information Technology Services Stocks Scanner - Computer Sciences, IMS Health Holdings, NCR Corp., and Unisys
PR Newswire - Wed Jun 08, 7:15AM CDT
On Tuesday, June 07, 2016, the NASDAQ Composite ended the trading session at 4,961.75, down 0.14%; the Dow Jones Industrial Average advanced 0.10% to finish at 17,938.28; and the S&P 500 closed at 2,112.13, up 0.13%. The gains were broad based as eight out of nine sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Computer Sciences Corporation (NYSE: CSC), IMS Health Holdings Inc. (NYSE: IMS), NCR Corporation (NYSE: NCR), and Unisys Corporation (NYSE: UIS). Learn more about these stocks by accessing their free trade alerts at:
IMS: 30.50 (+0.50), CSC: 51.57 (-0.30), NCR: 31.74 (-0.20), UIS: 9.45 (+0.04)
IMS Health Study: Global Market for Cancer Treatments Grows to $107 Billion in 2015, Fueled by Record Level of Innovation
BusinessWire - Wed Jun 01, 11:01PM CDT
More than 20 tumor types are being treated with one or more of the 70 new cancer treatments that have been launched in the past five years, with the sustained surge in innovative therapies driving the global oncology market to $107 billion in 2015. However, many of these drugs are not yet available to patients in most countries, and even when registered they may not be reimbursed under public insurance programs, according to a new study released today by the IMS Institute for Healthcare Informatics.
IMS: 30.50 (+0.50)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of IMS Health Holdings, Inc. to Quintiles Transnational Holdings, Inc.
BusinessWire - Thu May 26, 2:06PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
Privacy Analytics Acquired by IMS Health
CNW Group - Thu May 26, 8:30AM CDT
Integrating innovative data privacy expertise with a global healthcare information & technology service leader, strengthening and driving Ontario's digital healthcare security footprint
IMS: 30.50 (+0.50)
IMS Health Acquires Privacy Analytics, Advancing Real-World Evidence Technology to Drive R&D and Commercial Performance
BusinessWire - Wed May 25, 8:00AM CDT
IMS Health (NYSE:IMS) has acquired Privacy Analytics Incorporated, a leader in technology solutions for de-identifying and anonymizing healthcare information, to extend its robust Real-World Evidence (RWE) capabilities. Affirming IMS Health's long-standing practices for safeguarding patient privacy, the acquisition advances the company's ability to help life sciences clients drive R&D and commercial performance and demonstrate treatment value in real-world settings. It also reinforces IMS Health's role as a partner of choice for health systems, payers, providers and researchers as they seek new insights from healthcare data--with strong support for responsible privacy management.
IMS: 30.50 (+0.50)
Harwood Feffer LLP Announces Investigation of IMS Health Holdings, Inc.
PR Newswire - Tue May 24, 3:16PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of IMS Health Holdings, Inc. ("IMS" or the "Company"
(NYSE: IMS) concerning the proposed acquisition of the Company by Quintiles Transnational Holdings Inc. ("Quintiles". IMS: 30.50 (+0.50)
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of IMS Health Holdings, Inc. to Quintiles Transnational Holdings, Inc.
BusinessWire - Mon May 23, 4:04PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMS: 30.50 (+0.50), Q: 79.41 (+1.28)
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of IMS Health Holdings, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Sat May 07, 5:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of IMS Health Holdings, Inc. ("IMS" or the "Company"
(NYSE: IMS) relating to the proposed buyout of the Company by Quintiles Transnational Holdings, Inc. IMS: 30.50 (+0.50)
